Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citalopram for Reflux Hypersensitivity and Functional Heartburn
NCT03499171Phase 4Unknown
- Sponsor
- UZ Leuven
- Start
- May 2019
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of citalopram in reflux hypersensitivity (RH), Functional heartburn (FH), sponsored by UZ Leuven. Status: unknown.
02
Drugs
citalopram
03
Conditions
reflux hypersensitivity (RH)Functional heartburn (FH)
Beyond the preview
Go deeper on NCT03499171.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03499171.